[关键词]
[摘要]
目的 培养DL-乳酸伏硫西汀的单晶,并对其进行结构表征。方法 通过溶剂挥发法制备DL-乳酸伏硫西汀单晶,并采用热重分析仪(TGA)、差示扫描量热仪(DSC)、傅立叶变换红外光谱仪(IR)、粉末X射线衍射仪(PXRD)和单晶X射线衍射仪(SXRD)对其结晶形态进行表征。结果 乙腈溶剂挥发法可以制备得到β晶型DL-乳酸伏硫西汀无色立方状单晶,其DSC和PXRD图谱与文献报道一致。单晶X射线衍射结果表明DL-乳酸伏硫西汀的化学计量式为C21H28N2O3S,相对分子质量为388.51,晶体密度为1.246 g/cm3,该晶胞属于单斜晶系,空间群为P21/c。结论 采用X射线单晶衍射确证了DL-乳酸伏硫西汀单晶的结构,为DL-乳酸伏硫西汀的进一步开发提供了研究基础。
[Key word]
[Abstract]
Objective To prepare single crystal of vortioxetine DL-lactate, and investigate the structure characterization. Methods Evaporation method was used to grow single crystals of vortioxetine DL-lactate, which were then characterized using thermal gravimetric analyzer (TGA), differential scanning calorimetry (DSC), Fourier transform infrared spectrometer (IR), powder X-ray diffraction (PXRD), and single X-ray diffraction (SXRD). Results Single colorless block crystal of vortioxetine DL-lactate form β could be obtained through acetonitrile evaporation. DSC graph and PXRD spectrum was in good agreement with data reported in literatures. SXRD results showed that the unit stoichiometric of vortioxetine DL-lactate was C21H28N2O3S, and the relative molecular mass was 388.51, and crystal density was 1.246 g/cm3. The unit cell belonged to a monoclinic system, and the space group was P21/c. Conclusion Crystal structure of vortioxetine DL-lactate is characterized by single X-ray diffraction, which provides a basis for the further development of vortioxetine DL-lactate.
[中图分类号]
R962
[基金项目]
泰安市科技创新发展项目(2020NS075);泰山学院引进人才科研启动基金项目(Y-01-2018012)